Study suggests scan could detect evidence of CTE in living patients

Ex-NFL players involved in brain tests

Share with others:

Print Email Read Later

For years, researchers have had to use tissue obtained posthumously to diagnose chronic traumatic encephalopathy, or CTE, the degenerative brain disease that has bedeviled athletes, soldiers and others who have suffered repeated head hits and concussions.

But a study published last week in The American Journal of Geriatric Psychiatry suggests that PET scans could one day be used to diagnose the disease in living patients.

Last year, five retired National Football League players who were 45 years and older and suffered from mood swings, depression and cognitive problems were given PET, or positron emission tomography, scans. The authors of the study said those scans revealed tau protein deposits in their brains, a signature of CTE. While not definitive, the distribution of tau in the retired players was consistent with those found in the autopsies of players who had CTE.

But the size of the group was tiny; far larger and more in-depth studies will be needed before PET scans can be used to identify the tau pathology in patients who are not already experiencing cognitive problems. Some doctors also questioned the accuracy of the dye used to identify tau deposits in the brain.

It may take years and perhaps decades for doctors to determine how much of a role head hits and brain trauma have in patients with CTE, as opposed to one's genetic predisposition and other health maladies like heart disease.

But the study is a first step toward the possibility of using PET scans to develop strategies to prevent the onset of the disease and provide treatment for those suffering from it.

"For the first time, it opens the possibility we can intervene and stop the inexorable decline" of those with CTE, said Julian Bailes, the co-director of the NorthShore Neurological Institute in Evanston, Ill., and originator of the research. "We are connecting more dots. This was the holy grail of CTE."

The players in the study received intravenous injections of FDDNP, a chemical marker designed to bind to deposits of amyloid beta plaques and neurofibrillary tau tangles that are signs of Alzheimer's disease. The FDDNP was then viewed on the PET scans, which were compared to those of healthy men of similar age, body mass, education and family history of dementia.

The tests were done at Semel Institute for Neuroscience and Human Behavior at the University of California, Los Angeles. The five players had all suffered at least one concussion. The players consisted of a linebacker, a guard, a center, a defensive lineman and a quarterback.

"Early detection of tau proteins may help us to understand what is happening sooner in the brains of these injured athletes," said Gary Small, a professor of psychiatry and biobehavioral sciences at the Semel Institute and the lead author of the study. "Our findings may also guide us in developing strategies and interventions to protect those with early symptoms, rather than try to repair damage once it becomes extensive."

The study was financed by the Brain Injury Research Institute, which was co-founded by Dr. Bailes; the Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; the Ahmanson Foundation; and the Parlow-Solomon Professorship.

Neuroscientists have been encouraged by the growing number of researchers who have added to the knowledge of concussions and head trauma, which they claim has traditionally been underfinanced. And while they are encouraged by the possibility that PET scans may be used to diagnose CTE in living patients, they would need to see larger studies to be convinced of its efficacy.

Researchers, too, have been limited to studying patients who have effectively been self-selected: football players, other athletes and soldiers, all of whom have shown significant symptoms of CTE. Larger studies tracking patients over many years need to be done to determine how prevalent the disease is in the general population and whether certain people are predisposed to getting the disease.

"We have to look more broadly and deeply at this," said Geoffrey Manley, professor of neurosurgery at the University of California, San Francisco. "We have too many one-offs."

He added: "There's little that substitutes for following these people for years. We are right at the very beginning of this."



You have 2 remaining free articles this month

Try unlimited digital access

If you are an existing subscriber,
link your account for free access. Start here

You’ve reached the limit of free articles this month.

To continue unlimited reading

If you are an existing subscriber,
link your account for free access. Start here